- UroToday Home
- Beyond the Abstracts
- Urologic Oncology
Renal Cancer
Cell Cycle Progression Score Has Potential Prognostic Value for Stage T1 Renal Cell Carcinomas - Beyond the Abstract
March 23, 2020
The Covalent CDK7 Inhibitor THZ1 Enhances Temsirolimus-Induced Cytotoxicity via Autophagy Suppression in Human Renal Cell Carcinoma - Beyond the Abstract
February 4, 2020
Oncologic Outcomes Following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses - Beyond the Abstract
January 16, 2020
Facts for Spontaneous Rupture of a Renal Cell Carcinoma with Fatal Bleeding - Beyond the Abstract
January 9, 2020
Improving IMDC Prognostic Prediction Through Evaluation of Initial Site of Metastasis in Patients With Metastatic Renal Cell Carcinoma - Beyond the Abstract
December 18, 2019
First-line Treatment of Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-analysis - Beyond the Abstract
November 20, 2019
Renal Cell Carcinoma Follow-Up - Is it Time to Abandon Ultrasound? - Beyond the Abstract
October 23, 2019
Assessment of Local Tumor Ablation and Non-interventional Management versus Partial Nephrectomy in T1a Renal Cell Carcinoma - Beyond the Abstract
October 23, 2019
Management of High Complexity Renal Masses in Partial Nephrectomy: A Multicenter Analysis - Beyond the Abstract
September 13, 2019
Unmarried Status Is a Barrier for Access to Treatment in Patients with Metastatic Renal Cell Carcinoma – Beyond the Abstract
September 13, 2019
Folic Acid Reduces Mucositis in Metastatic Renal Cell Carcinoma Patients: A Retrospective Study - Beyond the Abstract
September 13, 2019
Complication Rates, Failure to Rescue and In-hospital Mortality after Cytoreductive Nephrectomy in Older Patients - Beyond the Abstract
August 19, 2019